🔗 Permalink

Inventor profile of:

Michael Molhoj

City:

Munich

Country:

Germany

Published Applications:

Last publication date:

2026-02-19

Top Assignees for applications by Michael Molhoj

The entities that hold a legal rights for patent applications filed by inventor Molhoj Michael:

HOFFMANN-LA ROCHE INC. 23 Little Falls, NJ United States
AMGEN RESEARCH (MUNICH) GMBH 2 Munich, Germany
BRISTOL-MYERS SQUIBB COMPANY 1 Princeton, NJ United States
Takeda GmbH 1 Constance, Germany
Hoffman-La Rocher Inc. 1 Little Falls, NJ United States
Hoffman-La Roche Inc. 1 Little Falls, NJ United States
ENGMAB AG 1 Wilen, Switzerland
ENGMAB AG 1 Pfäffikon, Switzerland
TAKEDA GMBH 1 Konstanz, Germany

Recent patent applications by Molhoj Michael

Michael Molhoj from Munich, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-02-19

US20260049160A1

Chemistry; metallurgy

TETRAVALENT MULTISPECIFIC ANTIBODIES

#2 | 2025-12-11

US20250376523A1

Chemistry; metallurgy

HUMANIZED ANTI-HUMAN CD19 ANTIBODIES AND METHODS OF USE

#3 | 2025-09-25

US20250297025A1

Chemistry; metallurgy

BISPECIFIC ANTI-HUMAN A-BETA/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE

#4 | 2025-07-10

US20250223372A1

Chemistry; metallurgy

BISPECIFIC ANTI-HUMAN A-BETA/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE

#5 | 2023-11-16

US20230365702A1

Chemistry; metallurgy

BISPECIFIC ANTI-HUMAN A-BETA/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE

#6 | 2023-08-24

US20230265177A1

Chemistry; metallurgy

Humanized anti-Tau(PS422) antibodies and methods of use

#7 | 2022-11-17

US20220363771A1

Chemistry; metallurgy

MULTISPECIFIC ANTIBODIES

#8 | 2022-09-29

US20220306761A1

Chemistry; metallurgy

Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use

#9 | 2022-06-30

US20220204616A1

Chemistry; metallurgy

Humanized anti-human CD19 antibodies and methods of use

#10 | 2022-05-12

US20220144963A9

Chemistry; metallurgy

Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of use

#11 | 2022-02-17

US20220049020A1

Chemistry; metallurgy

TETRAVALENT MULTISPECIFIC ANTIBODIES

#12 | 2021-09-30

US20210301030A1

Chemistry; metallurgy

BISPECIFIC ANTI-HUMAN A-BETA/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE

#13 | 2021-07-01

US20210199653A1

Physics

Direct affinity measurement of human IgG1 binding multimeric antigens

#14 | 2021-07-01

US20210198383A1

Chemistry; metallurgy

Method for determining the in vivo interaction mode

#15 | 2021-05-13

US20210139571A1

Chemistry; metallurgy

Humanized anti-Tau(pS422) antibodies and methods of use

#16 | 2021-03-11

US20210070882A1

Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#17 | 2020-11-05

US20200347147A1

Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#18 | 2020-07-23

US20200231673A1

Chemistry; metallurgy

Bispecific T cell activating antigen binding molecules

#19 | 2020-07-09

US20200216554A1

Chemistry; metallurgy

BISPECIFIC ANTI-HUMAN CD20/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE

#20 | 2020-04-02

US20200103413A1

Physics

Method for detecting multispecific antibody light chain mispairing

#21 | 2018-10-04

US20180282409A1

Chemistry; metallurgy

Humanized anti-human CD19 antibodies and methods of use

#22 | 2018-08-09

US20180222993A1

Chemistry; metallurgy

Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use

#23 | 2018-08-09

US20180222992A1

Chemistry; metallurgy

Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of use

#24 | 2018-08-09

US20180222981A1

Chemistry; metallurgy

Bispecific T cell activating antigen binding molecules

#25 | 2018-08-09

US20180222980A1

Chemistry; metallurgy

Bispecific T cell activating antigen binding molecules

#26 | 2018-07-26

US20180207278A1

Human necessities

Liquid formulation comprising GM-CSF neutralizing compound

#27 | 2018-03-22

US20180079804A1

Chemistry; metallurgy

Humanized anti-tau(pS422) antibodies and methods of use

#28 | 2017-10-26

US20170306036A1

Chemistry; metallurgy

Bispecific antibodies against CD3ϵ and BCMA

#29 | 2017-10-26

US20170306018A1

Chemistry; metallurgy

Bispecific antibodies against CD3EPSILON and ROR1

#30 | 2017-08-31

US20170247441A1

Chemistry; metallurgy

Anti-ANG2 antibodies and methods of use

#31 | 2017-08-24

US20170240629A1

Chemistry; metallurgy

Bispecific antibodies and methods of use in ophthalmology

#32 | 2017-07-06

US20170190783A1

Chemistry; metallurgy

Bispecific T cell activating antigen binding molecules

#33 | 2017-06-22

US20170174786A1

Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#34 | 2017-05-25

US20170145116A1

Chemistry; metallurgy

TETRAVALENT MULTISPECIFIC ANTIBODIES

#35 | 2017-05-11

US20170129962A1

Chemistry; metallurgy

MULTISPECIFIC ANTIBODIES

#36 | 2016-12-29

US20160376352A1

Chemistry; metallurgy

Humanized anti-tau(pS422) antibodies and methods of use

#37 | 2016-03-17

US20160075785A1

Chemistry; metallurgy

Bispecific T cell activating antigen binding molecules

#38 | 2015-11-05

US20150314001A1

Human necessities

Liquid formulation comprising GM-CSF neutralizing compound

InventorID:

1344485 ⎘